EP1077705A4 - Kaliumkanalagonisten - Google Patents

Kaliumkanalagonisten

Info

Publication number
EP1077705A4
EP1077705A4 EP99921866A EP99921866A EP1077705A4 EP 1077705 A4 EP1077705 A4 EP 1077705A4 EP 99921866 A EP99921866 A EP 99921866A EP 99921866 A EP99921866 A EP 99921866A EP 1077705 A4 EP1077705 A4 EP 1077705A4
Authority
EP
European Patent Office
Prior art keywords
agonists
canal
potassium
potassium canal
canal agonists
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP99921866A
Other languages
English (en)
French (fr)
Other versions
EP1077705A1 (de
Inventor
Joseph J Salata
Jixin Wang
Michael C Sanguinetti
Nancy K Jurkiewicz
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of EP1077705A1 publication Critical patent/EP1077705A1/de
Publication of EP1077705A4 publication Critical patent/EP1077705A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
    • A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
    • A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP99921866A 1998-05-15 1999-05-11 Kaliumkanalagonisten Withdrawn EP1077705A4 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US8556298P 1998-05-15 1998-05-15
US85562P 1998-05-15
PCT/US1999/010264 WO1999059594A1 (en) 1998-05-15 1999-05-11 Potassium channel agonists

Publications (2)

Publication Number Publication Date
EP1077705A1 EP1077705A1 (de) 2001-02-28
EP1077705A4 true EP1077705A4 (de) 2002-04-17

Family

ID=22192459

Family Applications (1)

Application Number Title Priority Date Filing Date
EP99921866A Withdrawn EP1077705A4 (de) 1998-05-15 1999-05-11 Kaliumkanalagonisten

Country Status (5)

Country Link
EP (1) EP1077705A4 (de)
JP (1) JP2002515436A (de)
AU (1) AU747340C (de)
CA (1) CA2329916A1 (de)
WO (1) WO1999059594A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6743797B2 (en) * 2002-02-22 2004-06-01 Chantest, Inc. Methods for treating cardiac arrhythmia
US20160129084A1 (en) * 2013-03-06 2016-05-12 Acorda Therapeutics, Inc. Therapeutic Dosing of a Neuregulin or a Fragment Thereof for Treatment or Prophylaxis of Heart Failure

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995014470A1 (en) * 1993-11-22 1995-06-01 Merck & Co., Inc. Methods of treating cardiac arrhythmia
US5633247A (en) * 1989-12-08 1997-05-27 Merck & Co., Inc. Nitrogen-containing spirocycles

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5733905A (en) * 1993-07-29 1998-03-31 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5633247A (en) * 1989-12-08 1997-05-27 Merck & Co., Inc. Nitrogen-containing spirocycles
WO1995014470A1 (en) * 1993-11-22 1995-06-01 Merck & Co., Inc. Methods of treating cardiac arrhythmia

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
SALATA J. ET AL: "A novel benzodiazepine that activates cardiac slow delayed rectifier K+ currents", MOLECULAR PHARMACOLOGY, vol. 54, no. 1, July 1998 (1998-07-01), pages 220 - 229, XP001027554 *
SANGUINETTI M C, JURKIEWICZ N., SALATA J.: "Novel benzodiazepines that modulate slow delayed rectifier K channels", NAUNYN-SCHMIEDERBERGS ARCHIVES OF PHARMACOLOGY, vol. 358, no. 1(1), September 1998 (1998-09-01), pages sf45, XP001026937 *
See also references of WO9959594A1 *
WILLIAM WM MUIR ET AL: "Antiarrhythmic effects of diazepam during coronary artery occlusion in dogs", AM. J. VET. RES., vol. 36, no. 8, 1975, pages 1203 - 1206, XP001027631 *

Also Published As

Publication number Publication date
CA2329916A1 (en) 1999-11-25
WO1999059594A1 (en) 1999-11-25
AU747340B2 (en) 2002-05-16
AU747340C (en) 2003-07-24
EP1077705A1 (de) 2001-02-28
JP2002515436A (ja) 2002-05-28
AU3897299A (en) 1999-12-06

Similar Documents

Publication Publication Date Title
DK1070058T3 (da) (4-Arylsulfonylamino)-tetrahydropyran-4-carboxylsyrehydroxamider
DE69943195D1 (de) Kopfhörer
NO20006268D0 (no) <Beta>karbolinforbindelser
DE59911453D1 (de) Aktivkohlefilter
DE59912371D1 (de) Gleitschalungsfertiger
DK199801716A (da) Hovedsæt
DE59901560D1 (de) Retrograder tibianagel
DE59907306D1 (de) Fadenchangierung
EP1124578A4 (de) Neuartige immunadjuvanzien
DE69930340D1 (de) Reibahle
DE59903966D1 (de) Exzenterzahnradgetriebe
DE59908968D1 (de) Benzoylpyridazine
FI980517A0 (fi) Foerfarande foer handover
EP1005862A4 (de) Anti-chlamydia mittel
NO20003786D0 (no) Oftalmisk sammensetning
DE59913393D1 (de) Fadenchangierung
DE59908769D1 (de) N-arylsulfonyl-aminosäure-omega-amide
DE59903106D1 (de) Tripode-gleichlaufdrehgelenk
DE59901046D1 (de) Methylcyclotetradec-5-en-1-one
ID27962A (id) Pembuatan tetrahidrofuran
DE59808995D1 (de) Endomikroskopsystem
DE69907024D1 (de) Giessrohr
DE59900612D1 (de) Dispersionsazofarbstoffmischungen
DK1076660T3 (da) Substituerede (4-brompyrazol-3-yl)benzazoler
EP1043364A4 (de) Toner

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20001215

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

AX Request for extension of the european patent

Free format text: AL PAYMENT 20001215;LT PAYMENT 20001215;LV PAYMENT 20001215;MK PAYMENT 20001215;RO PAYMENT 20001215;SI PAYMENT 20001215

A4 Supplementary search report drawn up and despatched

Effective date: 20020306

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU NL PT SE

RIC1 Information provided on ipc code assigned before grant

Free format text: 7A 61K 31/55 A, 7A 61K 31/453 B, 7A 61P 9/00 B, 7A 61P 9/04 B, 7A 61P 9/06 B

17Q First examination report despatched

Effective date: 20030911

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20040323